# US 2020/0390376 A1 · Biocompatibility coating for continuous analyte measurement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0390376 A1
- Document ID: US20200390376A1
- Status: Published application
- Kind: A1
- Application number: 17/003,258
- Filed: 2020-08-26
- Published: 2020-12-17
- Earliest claimed: 2018-02-28
- Assignees: Roche Diabetes Care, Inc.
- Applicants: Roche Diabetes Care, Inc.
- Inventors: Peng Zou
- Web page: https://patentgrep.com/patent/US20200390376A1

## CPC

- A61B 5/14503: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors (A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- G01N 33/54393: {Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding}
- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- C12Q 1/006: {for glucose}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This disclosure relates to a biosensor for determining an analyte comprising a sensor module covered at least partially by a biocompatibility layer, wherein said biocompatibility layer comprises a polymer having —CO—NR1R2 side groups, wherein R1 and R2 are independently selected from —H and C1 to C6 alkyl. This disclosure further relates to a method for producing the biosensor, as well as to uses and methods of using related to the biosensor.

## Claims

### Claim 1

A biosensor for determining an analyte, comprising:
a sensor module covered at least partially by a biocompatibility layer;
wherein said biocompatibility layer comprises a polymer having —CO—NR1R2 side groups; and
wherein R1 and R2 are independently selected from —H and C1 to C6 alkyl.

### Claim 2 (depends on 1)

The biosensor of claim 1, wherein R1 and R2 are independently selected from —H and C1 to C3 alkyl.

### Claim 3 (depends on 1)

The biosensor of claim 1, wherein R1 and R2 are independently selected from methyl, —H, and ethyl.

### Claim 4 (depends on 1)

The biosensor of claim 1, wherein R1 and R2 are methyl.

### Claim 5 (depends on 1)

The biosensor of claim 1, wherein said polymer having —CO—NR1R2 side groups is obtained or obtainable from a composition comprising monomers of the general structure (I):
with R3 being a polymerizable group.

### Claim 6 (depends on 5)

The biosensor of claim 5, wherein R3 is selected from vinyl, propenyl and isopropenyl.

### Claim 7 (depends on 5)

The biosensor of claim 5, wherein R3 is vinyl.

### Claim 8 (depends on 1)

The biosensor of claim 1, wherein said polymer having —CO—NR1R2 side groups is a copolymer.

### Claim 9 (depends on 8)

The biosensor of claim 8, wherein the copolymer is a statistical copolymer.

### Claim 10 (depends on 1)

The biosensor of claim 1, wherein said polymer having —CO—NR1R2 side groups is a copolymer of mono-N- or di-N-substituted acrylamide monomers and/or O-substituted methacrylate monomers.

### Claim 11 (depends on 10)

The biosensor of claim 10, wherein the O-substituted methacrylate monomers are 4-Benzoylphenyl methacrylate monomers.

### Claim 12 (depends on 1)

The biosensor of claim 1, wherein said polymer has a chemical structure as indicated in formula (II) or (IIa):
wherein R4 is a cross-linkable or cross-linked side group, wherein n is from 0.01 to 0.99 and m is of from 0.99 to 0.01.

### Claim 13 (depends on 12)

The biosensor of claim 12, wherein the sum of m and n is 1.

### Claim 14 (depends on 12)

The biosensor of claim 12, wherein n is of from 0.5 to 0.99, m is of from 0.01 to 0.5, and wherein the sum of m and n is 1.

### Claim 15 (depends on 1)

The biosensor of claim 1, wherein said polymer comprises a chemical structure as indicated in formula (III), (IIIa), (IIIb) and/or (IIIc):
wherein n is from 0.01 to 0.99 and m is of from 0.99 to 0.01; and
wherein R5 is a further polymer molecule or a molecule of a diffusion membrane.

### Claim 16 (depends on 15)

The biosensor of claim 15, wherein the sum of m and n is 1.

### Claim 17 (depends on 1)

The biosensor of claim 1, further comprising a diffusion membrane, wherein said diffusion membrane comprises a hydrophilic polyurethane polymer.

### Claim 18 (depends on 1)

The biosensor of claim 1, wherein said biosensor is implantable.

### Claim 19 (depends on 1)

The biosensor of claim 1, wherein said biosensor is implantable subcutaneously.

### Claim 20 (depends on 1)

The biosensor of claim 1, wherein said analyte is selected from the group consisting of glucose, malate, ethanol, ascorbic acid, cholesterol, glycerol, urea, 3-hydroxybutyrate, lactate, pyruvate, ketones, and creatinine.

### Claim 21 (depends on 1)

The biosensor of claim 1, wherein said analyte is glucose.

### Claim 22 (depends on 1)

A method for producing an implantable biosensor for determining an analyte, comprising at least partially coating said biosensor with a biocompatibility layer as claimed in claim 1.

### Claim 23 (depends on 1)

A method for continuous determination of an analyte in a subject, wherein said method comprises determining said analyte by means of the biosensor according to claim 1.

### Claim 24 (depends on 23)

The method of claim 23, wherein said continuous determination has a duration of at least 1 week with the same biosensor.

### Claim 25 (depends on 23)

The method of claim 23, wherein said continuous determination has a duration of at least 2 weeks with the same biosensor.

### Claim 26 (depends on 23)

The method of claim 23, wherein said continuous determination has a duration of at least 3 weeks with the same biosensor.

### Claim 27 (depends on 23)

The method of claim 23, wherein said continuous determination has a duration of at least 4 weeks with the same biosensor.
